SKAP1-AS2: A Potential Drug Target and Biomarker (G105371807)

Target Name: SKAP1-AS2

NCBI ID: G105371807

SKAP1-AS2

Other Name(s): SKAP1 antisense RNA 2, transcript variant 1 | BTR | THRA1/BTR | SKAP1 antisense RNA 2

SKAP1-AS2: A Potential Drug Target and Biomarker

SKAP1-AS2 (SKAP1 antisense RNA 2, transcript variant 1) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. SKAP1-AS2 is a splicing enhancer RNA molecule that plays a critical role in regulating gene expression in various organisms, including humans. Its function is to enhance the translation of RNA molecules into proteins, which is essential for the development and maintenance of cellular structures and functions. SKAP1-AS2 has been shown to be involved in the regulation of various cellular processes , including cell adhesion, migration, and apoptosis.

The SKAP1 gene is located on chromosome 19 and encodes a protein that is involved in the regulation of splicing and the stability of RNA molecules. The SKAP1 gene has four splice variants, SKAP1-AS1, SKAP1-AS2, SKAP1-AS3, and SKAP1- AS4. These variants differ in their exonic and intronic sequences. SKAP1-AS2 is the most abundant splice variant and is widely expressed in various tissues and organs, including brain, heart, lung, and muscle.

SKAP1-AS2 has been shown to play a critical role in the regulation of gene expression. It has been shown to interact with various protein molecules, including ZNF2, NF-kappa-B, and p53. SKAP1-AS2 has been shown to regulate the translation of specific RNA molecules, includingmiRNA, snRNA, and pre-mRNA. It has also been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and apoptosis.

SKAP1-AS2 has been shown to be involved in the regulation of cell adhesion. Research has shown that SKAP1-AS2 is involved in the regulation of tight junction formation, which is a critical process that allows cells to maintain their structural integrity and to prevent the loss of cell contents. SKAP1-AS2 has been shown to interact with the protein known as ZNF2, which is a transcription factor that is involved in the regulation of cell adhesion. ZNF2 has been shown to play a critical role in the regulation of tight junction formation and has been shown to be involved in the development of various diseases, including cancer.

SKAP1-AS2 has also been shown to be involved in the regulation of cell migration. Research has shown that SKAP1-AS2 is involved in the regulation of the migration of cancer cells. SKAP1-AS2 has also been shown to interact with the protein known as Paxillin, which is a protein that is involved in the regulation of cell migration. Paxillin has been shown to play a critical role in the regulation of cell migration and has been shown to be involved in the development of various diseases, including cancer.

SKAP1-AS2 has also been shown to be involved in the regulation of apoptosis. Research has shown that SKAP1-AS2 is involved in the regulation of apoptosis, which is a critical process that allows cells to eliminate themselves when they are no longer needed. SKAP1- AS2 has been shown to interact with the protein known as Bcl-2, which is a protein that is involved in the regulation of apoptosis. Bcl-2 has been shown to play a critical role in the regulation of apoptosis and has been shown to be involved in the development of various diseases, including cancer.

In conclusion, SKAP1-AS2 is a non-coding RNA molecule that has been shown to play a critical role in the regulation of various cellular processes, including cell adhesion, migration, and apoptosis. Its function is to enhance the translation of RNA molecules into proteins, which is essential for the development and maintenance of cellular structures and functions. SKAP1-AS2 has been shown to interact with various protein molecules, including ZNF2, NF-kappa-B, and

Protein Name: SKAP1 Antisense RNA 2

The "SKAP1-AS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SKAP1-AS2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets